miR-25-3p ameliorates SAE by targeting the TLR4/NLRP3 axis

Xiaoyan Luo(University of South China), Qiaosheng Wang(First Affiliated Hospital of University of South China)
Metabolic Brain Disease
June 15, 2022
Cited by 20


Related Papers